Patents by Inventor Norma J. Jebbett

Norma J. Jebbett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of cell strains capable of propagating respiratory syncytial virus, compositions containing such virus and their use in diagnosis of respiratory syncytial virus infection
    Patent number: 5071758
    Abstract: Antigens specific to respiratory syncytial virus are produced on the surface of cells by:(1) culturing in vitro cells derived from a human or animal mucosa,(2) inoculating the cultured cells with respiratory syncytial virus, and(3) selecting virally infected cells from the culture.The resulting cells or the viral antigen(s) when partially or completely isolated from the cells have immunological and diagnostic uses in respect of infection by respiratory syncytial virus and may be used to isolate viral antibodies. A specific cell strain NM7 produced by this method from bovine nasal mucosal cells has respiratory syncytial virus antigens on its surface and its corresponding, uninfected cell strain NM5 can be infected similarly.
    Type: Grant
    Filed: January 27, 1989
    Date of Patent: December 10, 1991
    Assignee: National Research Development Corporation
    Inventors: Edward J. Stott, Lewis H. Thomas, Norma J. Jebbett
  • Production of viral antigens
    Patent number: 4517304
    Abstract: Antigens specific to respiratory syncytial virus are produced on the surface of cells by:(1) culturing in vitro cells derived from a human or animal mucosa,(2) inoculating the cultured cells with respiratory syncytial virus, and(3) selecting virally infected cells from the culture.The resulting cells or the viral antigen(s) when partially or completely isolated from the cells have immunological and diagnostic uses in respect of infection by respiratory syncytial virus and may be used to isolate viral antibodies. A specific cell strain NM7 produced by this method from bovine nasal mucosal cells has respiratory syncytial virus antigens on its surface and its corresponding, uninfected cell strain NM5 can be infected similarly.
    Type: Grant
    Filed: June 29, 1981
    Date of Patent: May 14, 1985
    Assignee: National Research Development Corporation
    Inventors: Edward J. Stott, Lewis H. Thomas, Norma J. Jebbett